Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
CHANGE IN RATINGS
upgraded at Morgan Stanley. ADSK was upgraded from Underweight to Equal-weight. Fundamental outlook is improving.
rated new Buy at Citigroup. ALK was initiated with a Buy rating. $75 price target. Company generates solid earnings and free cash flow.
upgraded at Citigroup from Hold to Buy. $210 price target. Company is improving its competitive position.
downgraded at Morgan Keegan. CNQR was downgraded from Outperform to Market Perform. Valuation call.
numbers lowered at Goldman. Shares of CNQR now seen reaching $51. Estimates also cut, given lower sales expectations. Neutral rating.
estimates, target lowered at Goldman. Shares of CSCO now seen reaching $23. Estimates also cut, given the company's lower sales guidance. Neutral rating.
downgraded at Deutsche. CSCO was downgraded from Buy to Hold. $22 price target. Company lowered its forward guidance.
downgraded at William Blair to Market Perform. Company lowered its forward guidance.
downgraded at Wunderlich from Buy to Hold. $22 price target. Company is seeing lower orders.Cisco downgraded by Deutsche Banks, William Blair and Wunderlich; estimates, target lowered at Goldman.
downgraded at Citigroup. FLEX was downgraded from Buy to Hold. Company generates about 10% of its sales from CSCO.
( GGW) downgraded at Citigroup. GWW was downgraded from Hold to Sell. Valuation call, as the company is already pricing in early-cycle growth. $118 price target.
upgraded at Morgan Stanley. INTC was upgraded from Equal-weight to Overweight. $26 price target. Valuation call, as the stock is already pricing in risks to growth.
downgraded at Citigroup from Buy to Hold. Company is leveraged to lower growth at CSCO.
downgraded at Citigroup from Buy to Hold. Valuation call, based on an $8 price target.
upgraded at Stifel to Buy from Hold. $100 price target. Company should continue to outperform its peers.
99 Cents Only
( NDN) upgraded at Deutsche from Hold to Buy. $18 price target. Company should expand its margins over the coming quarters.
upgraded at Barclays from Equal-weight to Overweight. Company should be able to sustain its sales growth momentum into 2011. $45 price target.
downgraded at Barclays from Overweight to Equal-weight. $22 price target. Company lacks near-term catalysts.
This article was written by a staff member of TheStreet.